SUBSCRIBERS
Drugmaker Takeda to zoom in on emerging markets
Published Wed, Feb 25, 2015 · 09:50 PM
Singapore
ASIA'S largest drugmaker Takeda Pharmaceutical has streamlined its Singapore operations in a move that reflects its focus on emerging markets.
Its new Biopolis office, costing an undisclosed sum, will now house its emerging-markets business unit headquarters that was previously based in Zurich, as well as its regional research and development centre and its vaccine business unit.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action